Antenatal Steroids at 35 Weeks: Benefit Assessment and Decision-Making

Betamethasone (2×12 mg IM 24h apart) or dexamethasone (4×6 mg IM 12h apart) accelerate fetal lung surfactant production. Benefit is gestational-age dependent:

Gestational AgeRDS ReductionNNT
24–28 wk~50%2–3
29–33 wk~40%3–4
34–36 wk~30%6–10
≥37 wkMinimal—

At 35 Weeks Specifically

  • Lungs are near maturity; baseline RDS risk ~2–5%.
  • Steroids further reduce RDS to ~1–3% (absolute risk reduction 1–3%).
  • Also ↓ IVH, NEC, need for surfactant/mechanical ventilation.
  • Single course is safe; no long-term neurodevelopmental harm in RCTs.

Decision Framework

  1. If delivery is imminent/planned <37 wk: Give steroids (ACOG/SMFM strong recommendation).
  2. If expectant management likely >7 days: Single rescue course may be considered if initial course >14 days prior (controversial; discuss with MFM).
  3. Maternal factors: Diabetes (transient hyperglycemia — monitor), chorioamnionitis (contraindicated — deliver instead), hypertension (no contraindication).

Shared decision-making: Review absolute benefit (small at 35 wk), minimal risks, and patient values. Document discussion.

Pregnancy & Health - Related Articles